Latest Cancer vaccines Stories
AUSTIN, Texas, March 12, 2015 /PRNewswire/ -- XBiotech announced today that it has launched a website and call center to help patients with metastatic colorectal cancer learn about its U.S.
- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.
WORCESTER, Mass. and TORONTO, Feb.
Bankruptcy Court formally approved Valeant's role as a stalking horse bidder LAVAL, Quebec, Feb. 5, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
LAVAL, Quebec, Jan. 29, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
Analysis of Phase I Trial indicates Safety and positive immune response data in 21 of 21 patients administered Folate Receptor Alpha Vaccine for breast and ovarian cancers SEATTLE,
Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.
- An armed gangster.